Prevalence of chronic diseases among older patients in German general practices

Louis Jacob1, Jessica Breuer2, Karel Kostev3

  • 1Department of Biology, École Normale Supérieure de Lyon, Lyon, France.

Insights

Chronic diseases are highly prevalent in Germany's elderly population. Hypertension is the most common, with about 25% of patients having four or more chronic conditions (CDs).

Area of Science:

  • Geriatric Medicine
  • Public Health
  • Epidemiology

Background:

  • Chronic diseases (CDs) represent a significant health burden in aging populations worldwide.
  • Understanding the prevalence of specific CDs in older adults is crucial for healthcare planning and resource allocation.
  • German general practices (GPs) serve a large segment of the elderly population, making them ideal settings for epidemiological studies.

Purpose of the Study:

  • To determine the prevalence of ten common chronic diseases (CDs) among individuals aged 65 and older in German general practices.
  • To identify the most and least frequent CDs within this demographic.
  • To assess the burden of multiple comorbidities in elderly patients.

Main Methods:

  • Retrospective analysis of a large cohort of 840,319 patients aged over 65 years who visited German GPs in 2014.
  • Data included diagnoses for ten specific CDs: hypertension, lipid metabolism disorders, diabetes, coronary heart disease, cancer, chronic obstructive pulmonary disease (COPD), heart failure, stroke, chronic kidney disease (CKD), and osteoporosis.
  • Prevalence was calculated as the proportion of patients diagnosed with each condition.

Main Results:

  • All ten CDs were highly prevalent in the elderly cohort.
  • Hypertension was the most common CD, affecting approximately 66% of both men and women.
  • More than half of the patients had one to three CDs, and around 25% had four or more CDs.

Conclusions:

  • The study confirms a high prevalence of chronic diseases (CDs) among the elderly population in Germany.
  • Hypertension is the leading chronic condition, underscoring its public health significance in this age group.
  • The high rate of multimorbidity (four or more CDs) highlights the complex healthcare needs of older German patients.
Abstract

Related Concept Videos

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion

In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
311
Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
345
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption01:22

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption

As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
799
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution01:00

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution

Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
330
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
314
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism

Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
315